0001659073-19-000005.txt : 20191118 0001659073-19-000005.hdr.sgml : 20191118 20191118124227 ACCESSION NUMBER: 0001659073-19-000005 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191118 DATE AS OF CHANGE: 20191118 EFFECTIVENESS DATE: 20191118 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Gala Therapeutics, Inc. CENTRAL INDEX KEY: 0001659073 IRS NUMBER: 474075510 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-334782 FILM NUMBER: 191226710 BUSINESS ADDRESS: STREET 1: 155 JEFFERSON STREET STREET 2: SUITE 100 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-257-7535 MAIL ADDRESS: STREET 1: 155 JEFFERSON STREET STREET 2: SUITE 100 CITY: MENLO PARK STATE: CA ZIP: 94025 D/A 1 primary_doc.xml X0708 D/A LIVE 0001659073 Gala Therapeutics, Inc. 155 JEFFERSON STREET SUITE 100 MENLO PARK CA CALIFORNIA 94025 650-257-7535 DELAWARE None None Corporation true 2015 Jonathan Waldstreicher c/o Gala Therapeutics, Inc. 155 Jefferson Street, Suite 100 Menlo Park CA CALIFORNIA 94025 Executive Officer Director Seth Harrison c/o Gala Therapeutics, Inc. 155 Jefferson Street, Suite 100 Menlo Park CA CALIFORNIA 94025 Director Biotechnology Decline to Disclose 06b true 0001659073-19-000003 2015-10-08 true true false 0 43000000 42514946 485054 false 1 0 0 0 false Gala Therapeutics, Inc. /s/ Jonathan Waldstreicher Jonathan Waldstreicher Presiden & CEO 2019-11-18